» Articles » PMID: 31011522

Long Noncoding RNA UCA1 Promotes Osteosarcoma Metastasis Through CREB1-mediated Epithelial-mesenchymal Transition and Activating PI3K/AKT/mTOR Pathway

Overview
Journal J Bone Oncol
Publisher Elsevier
Date 2019 Apr 24
PMID 31011522
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidences have demonstrated that Long noncoding RNAs (lncRNAs) are key regulatory RNAs that participate in multiple biological processes. LncRNA urothelial carcinoma-associated 1 () is a newly identified lncRNA and functions as a regulator of growth in several cancers. However, the biological function and molecular mechanism of in the metastasis of osteosarcoma remain unclear. In this study, we firstly found is upregulated in both osteosarcoma tissues and cell lines, and increased is associated with higher tumor stage, larger tumor size and poorer prognosis. Then for the first time, we demonstrated that promotes the invasion and metastasis of osteosarcoma both and . Further mechanistic investigation showed that directly interactes with miR-582 and suppresses its expression. Moreover, increases CREB1 expression by functioning as a ceRNA against miR-582, thus promoting the EMT process via CREB1-mediated PI3K/AKT/mTOR pathway and finally leading to osteosarcoma metastasis. These findings may extend the function of in osteosarcoma progression and provide a promising therapeutic target for osteosarcoma treatment.

Citing Articles

Role of long noncoding RNAs in the regulation of epithelial‑mesenchymal transition in osteosarcoma (Review).

Li Z, Tian Y Oncol Rep. 2025; 53(3).

PMID: 39930817 PMC: 11783035. DOI: 10.3892/or.2025.8868.


Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma.

Shao W, Feng Y, Huang J, Li T, Gao S, Yang Y Open Life Sci. 2024; 19(1):20220936.

PMID: 39119480 PMC: 11306965. DOI: 10.1515/biol-2022-0936.


Osteosarcoma in a ceRNET perspective.

Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A J Biomed Sci. 2024; 31(1):59.

PMID: 38835012 PMC: 11151680. DOI: 10.1186/s12929-024-01049-y.


Emerging roles of long non-coding RNAs in osteosarcoma.

Liao X, Wei R, Zhou J, Wu K, Li J Front Mol Biosci. 2024; 11:1327459.

PMID: 38516191 PMC: 10955361. DOI: 10.3389/fmolb.2024.1327459.


CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways.

Zhang M, Wang X, Zhao J, Yan J, He X, Qin D Mol Biotechnol. 2023; 66(9):2241-2253.

PMID: 37608076 PMC: 11424664. DOI: 10.1007/s12033-023-00812-0.


References
1.
Hong J, Hwang E, McManus M, Amsterdam A, Tian Y, Kalmukova R . TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005; 309(5737):1074-8. DOI: 10.1126/science.1110955. View

2.
Wang X, Zhang Z, Wang H, Cai J, Xu Q, Li M . Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006; 12(16):4851-8. DOI: 10.1158/1078-0432.CCR-06-0134. View

3.
Yap T, Garrett M, Walton M, Raynaud F, de Bono J, Workman P . Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol. 2008; 8(4):393-412. DOI: 10.1016/j.coph.2008.08.004. View

4.
Acloque H, Adams M, Fishwick K, Bronner-Fraser M, Nieto M . Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009; 119(6):1438-49. PMC: 2689100. DOI: 10.1172/JCI38019. View

5.
Uchino K, Takeshita F, Takahashi R, Kosaka N, Fujiwara K, Naruoka H . Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol Ther. 2013; 21(3):610-9. PMC: 3589153. DOI: 10.1038/mt.2012.269. View